5-HTP is a serotonin precursor with medium-strength evidence for short-term appetite and weight support in overweight adults and multi-symptom fibromyalgia relief. Depression, migraine, and sleep evidence is thinner or mixed. Risks are gastrointestinal adverse effects and dangerous combinations with antidepressants or other drugs that raise serotonin. Appears as a situational, time-limited tool for specific targets—not a foundational longevity essential. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Weight / waist | Individual goal trajectory | Tracks appetite effect |
| Sleep metrics | Improved continuity & morning restoration | Primary endpoint for many users |
| Mood / anxiety scores | Stable or improved vs baseline | Detect benefit or activation |
| Blood pressure / heart rate | Stay at personal baseline | Autonomic side effects |
| Comprehensive metabolic panel | Within age-adjusted functional targets | General safety if high-dose/long-term |
| CBC with differential | Eosinophils within low-normal functional band | Historical EMS vigilance |
| Vitamin B6 (PLP) | Plasma PLP in mid-to-upper functional sufficiency range | Cofactor for AADC |
| Urinary 5-HIAA | Only if clinically indicated | Carcinoid workups (hold 5-HTP before testing) |
Cadence: Symptom and side-effect check at 3–7 days, again at 2–4 weeks, then every 4–8 weeks if continued